SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-24-008326
Filing Date
2024-05-15
Accepted
2024-05-15 17:27:16
Documents
64
Period of Report
2024-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q tmb-20240331x10q.htm   iXBRL 10-Q 960860
2 EX-10.5 tmb-20240331xex10d5.htm EX-10.5 104339
3 EX-31.1 tmb-20240331xex31d1.htm EX-31.1 10556
4 EX-31.2 tmb-20240331xex31d2.htm EX-31.2 10406
5 EX-32.1 tmb-20240331xex32d1.htm EX-32.1 6620
6 EX-32.2 tmb-20240331xex32d2.htm EX-32.2 6313
  Complete submission text file 0001558370-24-008326.txt   4763562

Data Files

Seq Description Document Type Size
7 EX-101.SCH tmb-20240331.xsd EX-101.SCH 34283
8 EX-101.CAL tmb-20240331_cal.xml EX-101.CAL 29964
9 EX-101.DEF tmb-20240331_def.xml EX-101.DEF 145014
10 EX-101.LAB tmb-20240331_lab.xml EX-101.LAB 318815
11 EX-101.PRE tmb-20240331_pre.xml EX-101.PRE 250147
68 EXTRACTED XBRL INSTANCE DOCUMENT tmb-20240331x10q_htm.xml XML 714745
Mailing Address 12 PENNS TRAIL NEWTOWN PA 18940
Business Address 12 PENNS TRAIL NEWTOWN PA 18940 267-759-3680
Traws Pharma, Inc. (Filer) CIK: 0001130598 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36020 | Film No.: 24952724
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)